US health panel recommends easing restrictions on controversial peptides

A federal health advisory panel narrowly recommended easing access to several peptides popular with celebrities and wellness influencers. The outside experts advised the Food and Drug Administration to remove restrictions preventing pharmacies from producing injectable peptides such as BPC-157, TB-500, and KPV. This recommendation occurred despite strong objections and warnings from government career scientists, who stated that these specific chemicals have not been proven safe or effective for human use in these applications.